Ocular Inflammation and Pain - Pipeline Insight, 2021
SKU ID : DEL-19306969 | Publishing Date : 12-Oct-2021 | No. of pages : 60
Detailed TOC of Ocular Inflammation and Pain - Pipeline Insight, 2021
IntroductionExecutive Summary
Ocular Inflammation and Pain: Overview
• Causes
• Mechanism of Action
• Signs and Symptoms
• Diagnosis
• Disease Management
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Late Stage Products (Phase III)
• Comparative Analysis
APP13007: Formosa pharmaceuticals
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
RX-10045: A.T. Resolve SARL
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Early stage products (Phase I/II)
• Comparative Analysis
Drug Name: Company Name
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Ocular Inflammation and Pain Key Companies
Ocular Inflammation and Pain Key Products
Ocular Inflammation and Pain- Unmet Needs
Ocular Inflammation and Pain- Market Drivers and Barriers
Ocular Inflammation and Pain- Future Perspectives and Conclusion
Ocular Inflammation and Pain Analyst Views
Ocular Inflammation and Pain Key Companies
Appendix
List of Figures, Tables and Charts Available in Ocular Inflammation and Pain - Pipeline Insight, 2021
Table 1 Total Products for Ocular Inflammation and PainTable 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products
Keyplayers in Ocular Inflammation and Pain - Pipeline Insight, 2021
• Formosa Pharmaceuticals, Inc.• Sun Pharma Advanced Research Company Limited
• Sun Pharma Global FZE
• A.T. Resolve SARL
• Tarsius Pharma
• SALVAT